An agreement worth $2.5 million to settle a class action securities fraud suit was reached last week between Norcross, Ga.-based Immucor, a medical supply company specializing in blood testing and transfusion products, and attorneys representing stock purchasers alleging the firm’s officers issued misleading information concerning its financial health in 2004 and 2005.

A suit filed Aug. 31, 2005, said the company misled investors as to the impact of a criminal investigation of its Italian subsidiary and that unit’s president, Dr. Gioacchino De Chirico, who has since been named Immucor’s president.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]